Today NOXXON announced that is has successfully administered its NOX-A12 aptamer-based mobilizer to healthy volunteers as part of a Phase I clinical trial.
Do the growth factors made by stem cells in response to injury are actually made by the stem cells, or whether the stem cells are “instructing” the injured tissue to make growth factors.
A paper published today from the Mary Laughlin’s group describes the use of cord blood cells in creation of new blood vessels.
In a recent paper the use of mesenchymal stem cells was evaluated after the cells have been stored frozen.
Geron stated that subsequent to their recent discussions with the FDA, they believe they will have sufficient new animal data to allow for continuation of the trial sometime in thei third quarter of 2010.
Stem Cell Therapeutics is a biotechnology company from Calgary Canada that is developing a novel type of stem cell therapy: instead of administering stem cells, they give drugs that activate the patient’s own stem cells.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2024, Stem Cell Insitute Panama. All rights reserved.
